Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-Retroviral Agent”

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT04301076
What this trial is testing

Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)

Who this might be right for
Acute Adult T-Cell Leukemia/LymphomaAdult T-Cell Leukemia/LymphomaChronic Adult T-Cell Leukemia/Lymphoma+1 more
National Cancer Institute (NCI) 30
Early research (Phase 1)Study completedNCT00011479
What this trial is testing

Blood Levels of Abacavir After One Dose in HIV-Infected Children and Adolescents

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 24
Not applicableStudy completedNCT00016601
What this trial is testing

Depo-Medroxyprogesterone Acetate (DMPA, Depo-Provera) Use With Certain Anti-HIV Drugs in HIV-Infected Women

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 76
Not applicableStudy completedNCT00002430
What this trial is testing

Compare the Effectiveness of Two Anti-HIV Drug Combinations

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 220
Testing effectiveness (Phase 2)Study completedNCT00012519
What this trial is testing

Ritonavir and Indinavir in Children Failing Other Anti-HIV Treatment

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 29
Testing effectiveness (Phase 2)WithdrawnNCT00000752
What this trial is testing

Preventing Frequent Sinus Infections in HIV-Infected Patients

Who this might be right for
HIV InfectionsSinusitis
National Institute of Allergy and Infectious Diseases (NIAID)
Testing effectiveness (Phase 2)Study completedNCT00002233
What this trial is testing

A Combination of Four Drugs in Patients With Recent HIV Infection

Who this might be right for
HIV Infections
Glaxo Wellcome 30
Not applicableStudy completedNCT00000895
What this trial is testing

Learn More About MAC Disease and the Use of Anti-HIV Drugs in Patients With Advanced HIV Infection

Who this might be right for
Mycobacterium Avium-intracellulare InfectionHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 85
Large-scale testing (Phase 3)Study completedNCT00002178
What this trial is testing

A Phase IIIB Open-Label, Comparative Study to Evaluate Saquinavir Soft Gel Capsule (SGC) Treatment in Combination With Other Antiretrovirals in HIV-1 Infected Antiretroviral-Naive Patients

Who this might be right for
HIV Infections
Hoffmann-La Roche 375
Post-approval studies (Phase 4)UnknownNCT00005017
What this trial is testing

Effectiveness and Safety of Epivir/Ziagen/Zerit (3TC/ABC/d4T) Versus Epivir/Ziagen/Sustiva (3TC/ABC/EFV) Versus Epivir/Ziagen/Agenerase/Norvir (3TC/ABC/APV/RTV) in HIV Patients Who Have Never Received Treatment

Who this might be right for
HIV Infections
Glaxo Wellcome 300
Testing effectiveness (Phase 2)Study completedNCT00001085
What this trial is testing

141W94 Used Alone or in Combination With Zidovudine Plus 3TC in HIV-Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 94
Testing effectiveness (Phase 2)Study completedNCT00002361
What this trial is testing

Safety and Effectiveness of an Anti-HIV Drug Combination in HIV-Positive Patients Who Have Failed Previous Treatment With Protease Inhibitors

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 30
Testing effectiveness (Phase 2)Study completedNCT00027339
What this trial is testing

Using Drug Levels and Drug Resistance Testing to Select Effective Anti-HIV Drug Combinations in Patients With Drug-resistant HIV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 53
Large-scale testing (Phase 3)UnknownNCT00004981
What this trial is testing

Safety and Effectiveness of Three Anti-HIV Drugs Combined in One Pill (Trizivir)

Who this might be right for
HIV Infections
Glaxo Wellcome 230
Testing effectiveness (Phase 2)Study completedNCT00000948
What this trial is testing

Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 72
Testing effectiveness (Phase 2)Study completedNCT00001048
What this trial is testing

Comparison of Anti HIV Drugs Used Alone or in Combination With Cytosine Arabinoside to Treat Progressive Multifocal Leukoencephalopathy (PML) in HIV-Infected Patients

Who this might be right for
HIV InfectionsLeukoencephalopathy, Progressive Multifocal
National Institute of Allergy and Infectious Diseases (NIAID) 90
Not applicableStudy completedNCT00051831
What this trial is testing

Effect of an Enfuvirtide-based Anti-HIV Drug Regimen on Latent HIV Reservoirs in Treatment Naive Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 19
Early research (Phase 1)Study completedNCT00001005
What this trial is testing

Zidovudine Plus Interleukin-2 in HIV-Infected Patients Who Have No Symptoms of Infection But Who Have Tender Lymph Nodes

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 30
Post-approval studies (Phase 4)Study completedNCT00005018
What this trial is testing

Safety and Effectiveness of a Combination Anti-HIV Drug Treatment

Who this might be right for
HIV Infections
Glaxo Wellcome 150
Not applicableStudy completedNCT00001097
What this trial is testing

Long-Term Effects of HAART in Youth With Stronger Immune Systems Versus Youth With Weaker Immune Systems

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 120
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation